Experienced in Upper Tract Urothelial Carcinoma (UTUC)

Dr. Perry W. Grigsby

Radiation Oncology
1 Barnes Jewish Hospital Plz, Dept Radiology, 
Saint Louis, MO 
Experienced in Upper Tract Urothelial Carcinoma (UTUC)
1 Barnes Jewish Hospital Plz, Dept Radiology, 
Saint Louis, MO 
OverviewInsuranceLocationsClinical Research

Overview

Perry Grigsby is a Radiation Oncologist in Saint Louis, Missouri. Dr. Grigsby is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Cervical Cancer, Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, and Thyroidectomy.

His clinical research consists of co-authoring 109 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in MO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

1 Barnes Jewish Hospital Plz, Dept Radiology, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer (DeCRESCEndo)
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer (DeCRESCEndo)
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
A Phase I Study of PD-1 Inhibition With TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
A Phase I Study of PD-1 Inhibition With TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 21, 2025
Intervention Type: Radiation, Drug, Procedure
Study Drug: TSR-042
Study Phase: Phase 1
A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers
A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Radiation, Procedure
Study Phase: Not Applicable
A Pilot Study Evaluating the Safety and Feasibility of MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer
A Pilot Study Evaluating the Safety and Feasibility of MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer
Enrollment Status: Withdrawn
Publish Date: April 01, 2022
Intervention Type: Device, Radiation
Study Phase: Not Applicable
A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
Enrollment Status: Completed
Publish Date: November 22, 2021
Intervention Type: Radiation, Procedure
Study Phase: Not Applicable
Pilot Study of Ultrasound and Photoacoustic Imaging for Assessing Treatment Response of Cervical Cancer Patients
Pilot Study of Ultrasound and Photoacoustic Imaging for Assessing Treatment Response of Cervical Cancer Patients
Enrollment Status: Terminated
Publish Date: May 29, 2020
Intervention Type: Device
Study Phase: Not Applicable
Reproducibility of 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Reproducibility of 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Enrollment Status: Completed
Publish Date: April 05, 2019
Intervention Type: Device, Radiation
Study Phase: Phase 1
Pilot Study of MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
Pilot Study of MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
Enrollment Status: Completed
Publish Date: January 17, 2019
Intervention Type: Behavioral, Device
Study Phase: Phase 1
View 7 Less Clinical Trials

109 Total Publications

Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 29, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Grigsby's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile